Literature DB >> 7078032

[Variant creatine kinase isoenzymes: frequency and clinical significance (author's transl)].

P M Bayer, G Wider, W Unger, H Köhn, P Hajdusich, H Hotschek.   

Abstract

To estimate the incidence of variant creatine kinase (CK)isoenzymes, 1,191 unselected patients were screened by means of CK:CK - MB ratio. When CK - MB was higher than 20% of the total CK in the immunoinhibition test, and a myocardial infarction could be excluded, a CK-isoenzyme electrophoresis was performed. We found macro-CK-BB-emia in 13 patients, but only three of them had elevated total CK activity. All patients but two were at the typical age of over 60 years; two males were 2 and 9 years old. The clinical diagnosis in macro-CK-BB-emia was predominantly cardiocerebrovascular insufficiency due to arteriosclerosis. In 16 other patients, the presence of an isoenzyme migrating cathodically to CK-MM was found. In this group, a malignant metastatic tumor was found in eight cases, the rest predominantly suffered from severe liver disease. Presence of both variant CK isoenzymes may lead to diagnostic or therapeutic errors due to the altered CK:CK-MB ratio. According to our studies, a variant CK isoenzyme occurs in 2.6% of hospitalized patients, but this will lead to problems diagnosing acute myocardial infarction only in the group with elevated total CK (0.42% of our patients).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7078032     DOI: 10.1007/bf01721627

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  Determination of creatine kinase isoenzyme MB (CK-MB): comparison of methods and clinical evaluation.

Authors:  J W Fiolet; A F Willebrands; K I Lie; H F ter Welle
Journal:  Clin Chim Acta       Date:  1977-10-01       Impact factor: 3.786

2.  Macro creatine kinase BB in serum, and some data on its prevalence.

Authors:  P Urdal; S Landaas
Journal:  Clin Chem       Date:  1979-03       Impact factor: 8.327

3.  Further observations on the incidence and nature of atypical creatine kinase activity.

Authors:  S M Sax; J J Moore; J L Giegel; M Welsh
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

4.  Macro creatine kinase: a study on CK-linked immunoglobulin.

Authors:  H Yuu; S Ishizawa; Y Takagi; K Gomi; O Senju; T Ishii
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

5.  Apparent mitochondrial creatine kinase in the serum of a patient with metastatic cancer to the liver.

Authors:  J W Heinz; N J O'Donnell; J A Lott
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

6.  Atypical cathode-migrating creatine kinase isoenzyme and human breast carcinoma: a specific marker?

Authors:  T Z Liu; J T Shen; Y T Lee; S B Shohet
Journal:  Clin Chem       Date:  1980-11       Impact factor: 8.327

7.  [Macro-creatine kinase; circulating immunoglobulin enzyme complexes as cause of elevated CK-activities (author's transl)].

Authors:  W Stein; J Bohner
Journal:  Klin Wochenschr       Date:  1979-10-15

8.  Atypical serum creatine kinase isoenzyme pattern caused by complexing of creatine kinase-BB with immunoglobulins G and A1),2).

Authors:  E Jockers-Wretou; E Plessing
Journal:  J Clin Chem Clin Biochem       Date:  1979-11

9.  [Creatine kinase isoenzymes: idiopathic occurrence of creatine kinase BB activities in patient serum (author's transl)].

Authors:  H Lang; U Würzburg; D Neumeier; M Knedel; W Prellwitz; R Kattermann; H Schlebusch; J Schürmann
Journal:  Klin Wochenschr       Date:  1978-07-01

10.  Binding of enzyme--IgG complexes in human serum to Protein-A Sepharose CL-4B.

Authors:  K Bauer; P M Bayer; E Deutsch; F Gabl
Journal:  Clin Chem       Date:  1980-02       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.